Low c-Kit expression identifies primitive, therapy-resistant CML stem cells

Mansi Shah(Gujarat University), Ravi Bhatia(University of Alabama at Birmingham)

JCI Insight

November 22, 2022

10.1172/jci.insight.157421

Cited by 9

Related Papers

PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia

|Nature Genetics|2019|616

Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment

|Blood|2003|541

Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study

|Blood|2007|536

American Society of Clinical Oncology Statement: Achieving High-Quality Cancer Survivorship Care

|Journal of Clinical Oncology|2013|473

Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma

|Journal of Clinical Oncology|2017|468